CIPRO A 5ml

Indication

 

General: Urinary tract infections, Skin and soft tissue infections, Typhoid fever, Gonorrhea and other sexually transmitted diseases, Bacterial gastrointestinal infections, Bone and joint infections, Osteomyelitis, Infectious diarrhea, Surgical prophylaxis, Gynecological infection, Other infections.

Eye : For the treatment of corneal ulcers and conjunctivitis caused by Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus viridans, Pseudomonous aeruginosa etc.

Ear : Otitis externa, acute otitis media, chronic suppurative otitis media. Prophylaxis in otic surgeries such as mastoid surgery.

 

 

Dosage and Administration

 

Infection	Type of Severity	Unit Dose	Frequency	Usual Durations
Urinary tract	Acute Uncomplicated	100 mg or 250 mg	b.i.d	3 Days
Mild/Moderate	250 mg	b.i.d	7-14 days
Severe/Complicated	500 mg	b.i.d	7-14 days
Chronic Bacterial Prostatitis	Mild/Moderate	500 mg	b.i.d	28 days
Lower Respiratory Tract	Mild/Moderate	500 mg	b.i.d	7-14 days
Severe/Complicated	750 mg	b.i.d	7-14 days
Acute Sinusitis	Mild/Moderate	500 mg	b.i.d	10 days
Skin & Skin Structure	Mild/Moderate	500 mg	b.i.d	7-14 days
Severe/Complicated	750 mg	b.i.d	7-14 days
Bone and Joint	Mild/Moderate	500 mg	b.i.d	³ 4-6 Weeks
Severe/Complicated	750 mg	b.i.d	³ 4-6 Weeks
Intra-Abdominal	Complicated	500 mg	b.i.d	7-14 days
Infectious Diarrhea	Mild/Moderate/Severe	500 mg	b.i.d	5-7 days
Typhoid Fever	Mild/Moderate	500 mg	b.i.d	10 days
Urethral and Cervical Gonococcal Infections	Uncomplicated	250 mg	Single dose	Single dose
Inhalational anthrax (Post-exposure)	Adult	500 mg	b.i.d	60 days
Pediatric	15 mg/kg per dose, not to exceed 500 mg per dose	b.i.d	60 days